Vanderbilt Therapeutics (VT) CRS is a clinical research site located in Nashville, Tennessee, United States 37204.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Vanderbilt Therapeutics (VT) CRS has participated in 27 clinical trials with 2 currently active.
Therapeutic areas: HIV Infections, Major Depressive Disorder, Mild Neurocognitive Disorder.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt Therapeutics (VT) CRS has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt Therapeutics (VT) CRS has 27 clinical trials on record, with 2 currently active. Their work covers HIV Infections, Major Depressive Disorder, Mild Neurocognitive Disorder.
Vanderbilt Therapeutics (VT) CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.